| Literature DB >> 36271074 |
Magnus Zethoven1, Luciano Martelotto2, Andrew Pattison2, Blake Bowen2, Shiva Balachander2, Aidan Flynn2, Fernando J Rossello2, Annette Hogg1, Julie A Miller3,4, Zdenek Frysak5, Sean Grimmond2, Lauren Fishbein6, Arthur S Tischler7, Anthony J Gill8,9,10, Rodney J Hicks1, Patricia L M Dahia11, Roderick Clifton-Bligh8,9, Karel Pacak12, Richard W Tothill13,14.
Abstract
Pheochromocytomas (PC) and paragangliomas (PG) are rare neuroendocrine tumors associated with autonomic nerves. Here we use single-nuclei RNA-seq and bulk-tissue gene-expression data to characterize the cellular composition of PCPG and normal adrenal tissues, refine tumor gene-expression subtypes and make clinical and genotypic associations. We confirm seven PCPG gene-expression subtypes with significant genotype and clinical associations. Tumors with mutations in VHL, SDH-encoding genes (SDHx) or MAML3-fusions are characterized by hypoxia-inducible factor signaling and neoangiogenesis. PCPG have few infiltrating lymphocytes but abundant macrophages. While neoplastic cells transcriptionally resemble mature chromaffin cells, early chromaffin and neuroblast markers are also features of some PCPG subtypes. The gene-expression profile of metastatic SDHx-related PCPG indicates these tumors have elevated cellular proliferation and a lower number of non-neoplastic Schwann-cell-like cells, while GPR139 is a potential theranostic target. Our findings therefore clarify the diverse transcriptional programs and cellular composition of PCPG and identify biomarkers of potential clinical significance.Entities:
Year: 2022 PMID: 36271074 DOI: 10.1038/s41467-022-34011-3
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694